FDA steps up scrutiny of coronavirus antibody tests to ensure accuracy
The Food and Drug Administration, under fire for allowing more than 100 commercial coronavirus antibody tests on the market without review, moved Monday to assert oversight, saying the tests will have to pass agency muster, including meeting standards for quality and accuracy.
View original article
Contributor: Laurie McGinley
